JP2007515249A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007515249A5 JP2007515249A5 JP2006547034A JP2006547034A JP2007515249A5 JP 2007515249 A5 JP2007515249 A5 JP 2007515249A5 JP 2006547034 A JP2006547034 A JP 2006547034A JP 2006547034 A JP2006547034 A JP 2006547034A JP 2007515249 A5 JP2007515249 A5 JP 2007515249A5
- Authority
- JP
- Japan
- Prior art keywords
- absorbent material
- stent according
- poly
- young
- stent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000002250 absorbent Substances 0.000 claims 12
- 230000002745 absorbent Effects 0.000 claims 12
- 239000000463 material Substances 0.000 claims 11
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 6
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims 3
- 239000003607 modifier Substances 0.000 claims 3
- YIWUKEYIRIRTPP-UHFFFAOYSA-N 2-ethylhexan-1-ol Chemical compound CCCCC(CC)CO YIWUKEYIRIRTPP-UHFFFAOYSA-N 0.000 claims 2
- 102000009123 Fibrin Human genes 0.000 claims 2
- 108010073385 Fibrin Proteins 0.000 claims 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims 2
- 229920000954 Polyglycolide Polymers 0.000 claims 2
- 238000010521 absorption reaction Methods 0.000 claims 2
- 239000003146 anticoagulant agent Substances 0.000 claims 2
- 239000003963 antioxidant agent Substances 0.000 claims 2
- 210000004204 blood vessel Anatomy 0.000 claims 2
- -1 calcium antagonists Substances 0.000 claims 2
- 229920001577 copolymer Polymers 0.000 claims 2
- 229950003499 fibrin Drugs 0.000 claims 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 2
- 239000004014 plasticizer Substances 0.000 claims 2
- PUDHBTGHUJUUFI-SCTWWAJVSA-N (4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-n-[(2s,3r)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2r)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-p Chemical compound C([C@H]1C(=O)N[C@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](N)CC=1C=C2C=CC=CC2=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)=O)C(C)C)C1=CC=C(O)C=C1 PUDHBTGHUJUUFI-SCTWWAJVSA-N 0.000 claims 1
- QDTDKYHPHANITQ-UHFFFAOYSA-N 7-methyloctan-1-ol Chemical compound CC(C)CCCCCCO QDTDKYHPHANITQ-UHFFFAOYSA-N 0.000 claims 1
- PLLBRTOLHQQAQQ-UHFFFAOYSA-N 8-methylnonan-1-ol Chemical compound CC(C)CCCCCCCO PLLBRTOLHQQAQQ-UHFFFAOYSA-N 0.000 claims 1
- 239000005541 ACE inhibitor Substances 0.000 claims 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
- 229940127291 Calcium channel antagonist Drugs 0.000 claims 1
- 102000008186 Collagen Human genes 0.000 claims 1
- 108010035532 Collagen Proteins 0.000 claims 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims 1
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims 1
- 102000007625 Hirudins Human genes 0.000 claims 1
- 108010007267 Hirudins Proteins 0.000 claims 1
- 239000004440 Isodecyl alcohol Substances 0.000 claims 1
- 239000004439 Isononyl alcohol Substances 0.000 claims 1
- 229930195725 Mannitol Natural products 0.000 claims 1
- 108091034117 Oligonucleotide Proteins 0.000 claims 1
- 239000004952 Polyamide Substances 0.000 claims 1
- 229920002732 Polyanhydride Polymers 0.000 claims 1
- 239000004721 Polyphenylene oxide Substances 0.000 claims 1
- 229920000388 Polyphosphate Polymers 0.000 claims 1
- 229920002396 Polyurea Polymers 0.000 claims 1
- 229960001138 acetylsalicylic acid Drugs 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000000556 agonist Substances 0.000 claims 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 230000000340 anti-metabolite Effects 0.000 claims 1
- 230000002927 anti-mitotic effect Effects 0.000 claims 1
- 229940127219 anticoagulant drug Drugs 0.000 claims 1
- 239000003524 antilipemic agent Substances 0.000 claims 1
- 239000002256 antimetabolite Substances 0.000 claims 1
- 229940100197 antimetabolite Drugs 0.000 claims 1
- 239000003080 antimitotic agent Substances 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 claims 1
- 229940127218 antiplatelet drug Drugs 0.000 claims 1
- 229960004676 antithrombotic agent Drugs 0.000 claims 1
- 229960002537 betamethasone Drugs 0.000 claims 1
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 claims 1
- 239000012867 bioactive agent Substances 0.000 claims 1
- 229910052791 calcium Inorganic materials 0.000 claims 1
- 239000011575 calcium Substances 0.000 claims 1
- 229920001436 collagen Polymers 0.000 claims 1
- 239000003086 colorant Substances 0.000 claims 1
- 239000003431 cross linking reagent Substances 0.000 claims 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 1
- 229960003957 dexamethasone Drugs 0.000 claims 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000000945 filler Substances 0.000 claims 1
- 239000003862 glucocorticoid Substances 0.000 claims 1
- 150000004676 glycans Chemical class 0.000 claims 1
- 239000003102 growth factor Substances 0.000 claims 1
- 239000003966 growth inhibitor Substances 0.000 claims 1
- 229960002897 heparin Drugs 0.000 claims 1
- 229920000669 heparin Polymers 0.000 claims 1
- 229940006607 hirudin Drugs 0.000 claims 1
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 claims 1
- 239000000017 hydrogel Substances 0.000 claims 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 1
- 229960000448 lactic acid Drugs 0.000 claims 1
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 claims 1
- 229960002437 lanreotide Drugs 0.000 claims 1
- 108010021336 lanreotide Proteins 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 claims 1
- 229920000118 poly(D-lactic acid) Polymers 0.000 claims 1
- 229920001432 poly(L-lactide) Polymers 0.000 claims 1
- 229920000218 poly(hydroxyvalerate) Polymers 0.000 claims 1
- 229920000747 poly(lactic acid) Polymers 0.000 claims 1
- 229920002627 poly(phosphazenes) Polymers 0.000 claims 1
- 229920002647 polyamide Polymers 0.000 claims 1
- 229920000768 polyamine Polymers 0.000 claims 1
- 229920001610 polycaprolactone Polymers 0.000 claims 1
- 239000004632 polycaprolactone Substances 0.000 claims 1
- 229920000728 polyester Polymers 0.000 claims 1
- 229920000570 polyether Polymers 0.000 claims 1
- 229920002523 polyethylene Glycol 1000 Polymers 0.000 claims 1
- 229920002959 polymer blend Polymers 0.000 claims 1
- 239000001205 polyphosphate Substances 0.000 claims 1
- 235000011176 polyphosphates Nutrition 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000005017 polysaccharide Substances 0.000 claims 1
- 229920002635 polyurethane Polymers 0.000 claims 1
- 239000004814 polyurethane Substances 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 239000000600 sorbitol Substances 0.000 claims 1
- 229960001295 tocopherol Drugs 0.000 claims 1
- 229930003799 tocopherol Natural products 0.000 claims 1
- 235000010384 tocopherol Nutrition 0.000 claims 1
- 239000011732 tocopherol Substances 0.000 claims 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 claims 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/740,806 US20050137678A1 (en) | 2003-12-22 | 2003-12-22 | Low profile resorbable stent |
| PCT/US2004/040365 WO2005065581A1 (en) | 2003-12-22 | 2004-12-02 | Low profile resorbable stent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007515249A JP2007515249A (ja) | 2007-06-14 |
| JP2007515249A5 true JP2007515249A5 (enExample) | 2008-01-31 |
Family
ID=34677970
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006547034A Abandoned JP2007515249A (ja) | 2003-12-22 | 2004-12-02 | 低プロファイル吸収性ステント |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20050137678A1 (enExample) |
| EP (1) | EP1718244A1 (enExample) |
| JP (1) | JP2007515249A (enExample) |
| WO (1) | WO2005065581A1 (enExample) |
Families Citing this family (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7208010B2 (en) | 2000-10-16 | 2007-04-24 | Conor Medsystems, Inc. | Expandable medical device for delivery of beneficial agent |
| US6241762B1 (en) | 1998-03-30 | 2001-06-05 | Conor Medsystems, Inc. | Expandable medical device with ductile hinges |
| US7179289B2 (en) * | 1998-03-30 | 2007-02-20 | Conor Medsystems, Inc. | Expandable medical device for delivery of beneficial agent |
| JP2004511297A (ja) | 2000-10-16 | 2004-04-15 | コナー メドシステムズ， インコーポレイテッド | 有益な薬剤を搬送するための拡張可能な医療装置 |
| US7842083B2 (en) | 2001-08-20 | 2010-11-30 | Innovational Holdings, Llc. | Expandable medical device with improved spatial distribution |
| US20090012598A1 (en) * | 2004-06-29 | 2009-01-08 | Abbate Anthony J | Method of fabricating an implantable medical device by deformation of a tube or a sheet |
| US8778256B1 (en) | 2004-09-30 | 2014-07-15 | Advanced Cardiovascular Systems, Inc. | Deformation of a polymer tube in the fabrication of a medical article |
| US20060020330A1 (en) | 2004-07-26 | 2006-01-26 | Bin Huang | Method of fabricating an implantable medical device with biaxially oriented polymers |
| US7971333B2 (en) | 2006-05-30 | 2011-07-05 | Advanced Cardiovascular Systems, Inc. | Manufacturing process for polymetric stents |
| US8747879B2 (en) | 2006-04-28 | 2014-06-10 | Advanced Cardiovascular Systems, Inc. | Method of fabricating an implantable medical device to reduce chance of late inflammatory response |
| US8012402B2 (en) | 2008-08-04 | 2011-09-06 | Abbott Cardiovascular Systems Inc. | Tube expansion process for semicrystalline polymers to maximize fracture toughness |
| US8268228B2 (en) * | 2007-12-11 | 2012-09-18 | Abbott Cardiovascular Systems Inc. | Method of fabricating stents from blow molded tubing |
| US20110066222A1 (en) * | 2009-09-11 | 2011-03-17 | Yunbing Wang | Polymeric Stent and Method of Making Same |
| US7731890B2 (en) * | 2006-06-15 | 2010-06-08 | Advanced Cardiovascular Systems, Inc. | Methods of fabricating stents with enhanced fracture toughness |
| US9517149B2 (en) | 2004-07-26 | 2016-12-13 | Abbott Cardiovascular Systems Inc. | Biodegradable stent with enhanced fracture toughness |
| US8501079B2 (en) | 2009-09-14 | 2013-08-06 | Abbott Cardiovascular Systems Inc. | Controlling crystalline morphology of a bioabsorbable stent |
| US8043553B1 (en) | 2004-09-30 | 2011-10-25 | Advanced Cardiovascular Systems, Inc. | Controlled deformation of a polymer tube with a restraining surface in fabricating a medical article |
| US8173062B1 (en) | 2004-09-30 | 2012-05-08 | Advanced Cardiovascular Systems, Inc. | Controlled deformation of a polymer tube in fabricating a medical article |
| US7875233B2 (en) * | 2004-09-30 | 2011-01-25 | Advanced Cardiovascular Systems, Inc. | Method of fabricating a biaxially oriented implantable medical device |
| US7914573B2 (en) * | 2005-12-13 | 2011-03-29 | Cordis Corporation | Polymeric stent having modified molecular structures |
| US20070158880A1 (en) * | 2006-01-06 | 2007-07-12 | Vipul Bhupendra Dave | Methods of making bioabsorbable drug delivery devices comprised of solvent cast tubes |
| US20070162110A1 (en) * | 2006-01-06 | 2007-07-12 | Vipul Bhupendra Dave | Bioabsorbable drug delivery devices |
| US20070160672A1 (en) * | 2006-01-06 | 2007-07-12 | Vipul Bhupendra Dave | Methods of making bioabsorbable drug delivery devices comprised of solvent cast films |
| ATE520425T1 (de) * | 2006-02-07 | 2011-09-15 | Tepha Inc | Verstärkte polymilchsäurepolymere und -copolymere |
| US8979921B2 (en) * | 2006-02-07 | 2015-03-17 | Tepha, Inc. | Polymeric, degradable drug-eluting stents and coatings |
| US9592325B2 (en) * | 2006-02-07 | 2017-03-14 | Tepha, Inc. | Polymeric, degradable drug-eluting stents and coatings |
| CA2644247A1 (en) * | 2006-03-03 | 2007-09-13 | Prescient Medical,Inc. | Endoluminal prostheses for treating vulnerable plaque |
| JP4828268B2 (ja) * | 2006-03-16 | 2011-11-30 | テルモ株式会社 | ステント |
| US20070225472A1 (en) * | 2006-03-23 | 2007-09-27 | Varshney Sunil K | Polyanhydride polymers and their uses in biomedical devices |
| US20070225795A1 (en) * | 2006-03-24 | 2007-09-27 | Juan Granada | Composite vascular prosthesis |
| US9320837B2 (en) * | 2006-05-12 | 2016-04-26 | CARDINAL HEALTH SWITZERLAND 515 GmbH | Balloon expandable bioabsorbable drug eluting flexible stent |
| US7594928B2 (en) * | 2006-05-17 | 2009-09-29 | Boston Scientific Scimed, Inc. | Bioabsorbable stents with reinforced filaments |
| US20070290412A1 (en) * | 2006-06-19 | 2007-12-20 | John Capek | Fabricating a stent with selected properties in the radial and axial directions |
| US7740791B2 (en) * | 2006-06-30 | 2010-06-22 | Advanced Cardiovascular Systems, Inc. | Method of fabricating a stent with features by blow molding |
| US20080014170A1 (en) * | 2006-07-14 | 2008-01-17 | Olexander Hnojewyj | Drug delivery polyanhydride composition and method |
| US9173733B1 (en) | 2006-08-21 | 2015-11-03 | Abbott Cardiovascular Systems Inc. | Tracheobronchial implantable medical device and methods of use |
| CA2667325A1 (en) * | 2006-10-23 | 2008-05-02 | Bioabsorbable Therapeutics, Inc. | A drug-release composition having a therapeutic carrier |
| US7943683B2 (en) * | 2006-12-01 | 2011-05-17 | Tepha, Inc. | Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers |
| US7666342B2 (en) * | 2007-06-29 | 2010-02-23 | Abbott Cardiovascular Systems Inc. | Method of manufacturing a stent from a polymer tube |
| US20090036964A1 (en) | 2007-08-01 | 2009-02-05 | Prescient Medical, Inc. | Expandable Prostheses for Treating Atherosclerotic Lesions Including Vulnerable Plaques |
| US9248219B2 (en) * | 2007-09-14 | 2016-02-02 | Boston Scientific Scimed, Inc. | Medical devices having bioerodable layers for the release of therapeutic agents |
| EP2228081A1 (en) | 2007-12-03 | 2010-09-15 | Goodman Co., Ltd. | Stent and method of producing the same |
| US7972373B2 (en) * | 2007-12-19 | 2011-07-05 | Advanced Technologies And Regenerative Medicine, Llc | Balloon expandable bioabsorbable stent with a single stress concentration region interconnecting adjacent struts |
| US20090319036A1 (en) * | 2008-06-19 | 2009-12-24 | Yunbing Wang | Medical Devices Made From Polymers With End Group Modification For Improved Thermal Stability |
| US8298466B1 (en) | 2008-06-27 | 2012-10-30 | Abbott Cardiovascular Systems Inc. | Method for fabricating medical devices with porous polymeric structures |
| US20100244304A1 (en) * | 2009-03-31 | 2010-09-30 | Yunbing Wang | Stents fabricated from a sheet with increased strength, modulus and fracture toughness |
| US8992601B2 (en) * | 2009-05-20 | 2015-03-31 | 480 Biomedical, Inc. | Medical implants |
| US9265633B2 (en) | 2009-05-20 | 2016-02-23 | 480 Biomedical, Inc. | Drug-eluting medical implants |
| US9526813B2 (en) * | 2009-07-13 | 2016-12-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Intraluminal polymeric devices for the treatment of aneurysms |
| WO2011096241A1 (ja) * | 2010-02-02 | 2011-08-11 | テルモ株式会社 | 生体内吸収性ステント |
| US8370120B2 (en) | 2010-04-30 | 2013-02-05 | Abbott Cardiovascular Systems Inc. | Polymeric stents and method of manufacturing same |
| JP5124703B2 (ja) * | 2010-10-29 | 2013-01-23 | オリンパスメディカルシステムズ株式会社 | 医療用ステントおよび医療用ステントの製造方法 |
| GB2512016A (en) | 2012-09-24 | 2014-09-24 | Arterius Ltd | Methods |
| WO2015119653A1 (en) | 2014-02-04 | 2015-08-13 | Abbott Cardiovascular Systems Inc. | Drug delivery scaffold or stent with a novolimus and lactide based coating such that novolimus has a minimum amount of bonding to the coating |
| EP3860825A4 (en) * | 2017-09-08 | 2022-06-15 | Zeus Company Inc. | Polymeric tubes with controlled orientation |
| CN114870097B (zh) * | 2017-09-08 | 2024-04-09 | 宙斯有限公司 | 具有控制的取向的聚合物管 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA393600A (en) * | 1937-05-19 | 1940-12-31 | Jacque Heinrich | Thermoplastic, film-forming and organic substance processing |
| US2767435A (en) * | 1952-06-05 | 1956-10-23 | Du Pont | Process for longitudinally stretching polymeric film |
| US3619460A (en) * | 1969-04-28 | 1971-11-09 | Chevron Res | Process for uniaxially orienting polypropylene films |
| US3627579A (en) * | 1969-11-18 | 1971-12-14 | Du Pont | Unidirectionally oriented film structure of polyethylene terephthalate |
| US3625924A (en) * | 1969-12-04 | 1971-12-07 | Gaf Corp | Oriented films of methyl vinyl ether-maleic anhydride copolymers |
| GB1371334A (en) * | 1970-10-30 | 1974-10-23 | Agfa Gevaert | Film stretching method and apparatus |
| GB1522382A (en) * | 1975-03-06 | 1978-08-23 | Agfa Gevaert | Process for making polymeric film |
| US5133732A (en) | 1987-10-19 | 1992-07-28 | Medtronic, Inc. | Intravascular stent |
| US5502158A (en) * | 1988-08-08 | 1996-03-26 | Ecopol, Llc | Degradable polymer composition |
| US6171338B1 (en) * | 1988-11-10 | 2001-01-09 | Biocon, Oy | Biodegradable surgical implants and devices |
| US5545208A (en) * | 1990-02-28 | 1996-08-13 | Medtronic, Inc. | Intralumenal drug eluting prosthesis |
| JPH0623836A (ja) * | 1992-07-09 | 1994-02-01 | Shimadzu Corp | ポリ乳酸延伸フィルムの製造方法 |
| WO1994021196A2 (en) * | 1993-03-18 | 1994-09-29 | C.R. Bard, Inc. | Endovascular stents |
| US5626611A (en) * | 1994-02-10 | 1997-05-06 | United States Surgical Corporation | Composite bioabsorbable materials and surgical articles made therefrom |
| FI98136C (fi) * | 1995-09-27 | 1997-04-25 | Biocon Oy | Kudosolosuhteissa hajoava materiaali ja menetelmä sen valmistamiseksi |
| US6287336B1 (en) | 1995-10-16 | 2001-09-11 | Medtronic, Inc. | Variable flexibility stent |
| US5756651A (en) * | 1996-07-17 | 1998-05-26 | Chronopol, Inc. | Impact modified polylactide |
| US5843168A (en) | 1997-03-31 | 1998-12-01 | Medtronic, Inc. | Double wave stent with strut |
| US6245103B1 (en) * | 1997-08-01 | 2001-06-12 | Schneider (Usa) Inc | Bioabsorbable self-expanding stent |
| US6156062A (en) * | 1997-12-03 | 2000-12-05 | Ave Connaught | Helically wrapped interlocking stent |
| US6533807B2 (en) | 1998-02-05 | 2003-03-18 | Medtronic, Inc. | Radially-expandable stent and delivery system |
| US6221075B1 (en) * | 1998-03-06 | 2001-04-24 | Bionx Implants Oy | Bioabsorbable, deformable fixation plate |
| US6019779A (en) * | 1998-10-09 | 2000-02-01 | Intratherapeutics Inc. | Multi-filar coil medical stent |
| US6517571B1 (en) * | 1999-01-22 | 2003-02-11 | Gore Enterprise Holdings, Inc. | Vascular graft with improved flow surfaces |
| US6331189B1 (en) | 1999-10-18 | 2001-12-18 | Medtronic, Inc. | Flexible medical stent |
| WO2002098476A1 (en) * | 2001-06-01 | 2002-12-12 | Ams Research Corporation | Bioresorbable medical devices |
| US7572287B2 (en) * | 2001-10-25 | 2009-08-11 | Boston Scientific Scimed, Inc. | Balloon expandable polymer stent with reduced elastic recoil |
| US6932930B2 (en) * | 2003-03-10 | 2005-08-23 | Synecor, Llc | Intraluminal prostheses having polymeric material with selectively modified crystallinity and methods of making same |
-
2003
- 2003-12-22 US US10/740,806 patent/US20050137678A1/en not_active Abandoned
-
2004
- 2004-12-02 JP JP2006547034A patent/JP2007515249A/ja not_active Abandoned
- 2004-12-02 WO PCT/US2004/040365 patent/WO2005065581A1/en not_active Ceased
- 2004-12-02 EP EP04812805A patent/EP1718244A1/en not_active Withdrawn
-
2007
- 2007-10-30 US US11/927,914 patent/US20080054511A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007515249A5 (enExample) | ||
| JP2007515250A5 (enExample) | ||
| CN103764076B (zh) | 可生物降解的内置假体及其制造方法 | |
| EP1773250B1 (en) | Bioabsorbable self-expanding endolumenal devices | |
| CN101156965B (zh) | 用于加速降解的具有复合结构的生物可吸收装置 | |
| ES2634698T3 (es) | Prótesis endovasculares y recubrimientos degradables poliméricos que liberan fármacos | |
| US9561611B2 (en) | Multilayer bioabsorbable scaffolds and methods of fabricating | |
| JP2007515249A (ja) | 低プロファイル吸収性ステント | |
| US20140336747A1 (en) | Bioresorbable implants for transmyocardial revascularization | |
| RU2009104348A (ru) | Стент (варианты) и катетерный баллон | |
| EP2731661A1 (en) | Drug elution medical device | |
| US20050149172A1 (en) | Minimal injury resorbable stent | |
| JPWO2016114216A1 (ja) | 生分解性ステント | |
| WO2025069037A1 (en) | A multi-layered matrix and uses thereof | |
| US20110223232A1 (en) | drug-release composition having a therapeutic carrier | |
| CN111601625A (zh) | 自膨型支架及其制造方法 | |
| US20070001346A1 (en) | Active embolization device | |
| JP2007313009A (ja) | ステント | |
| EP3522945B1 (en) | Laminary material for preventing post-surgical adhesions | |
| AU2012200186B2 (en) | Bioabsorbable self-expanding endolumenal devices | |
| US20140288582A1 (en) | Implant Localization Device |